Company intelligence / Profile preview

Ostro

Miami, Florida, United States

Ownership: Private
Employees: ~70
Development stage: Other

Overview

Ostro delivers AI-powered, compliant digital engagement solutions for life sciences, with proven increases in patient and HCP engagement. Their platform is deployed across multiple therapeutic areas and used by over half the top 20 global pharmaceutical companies to drive commercial and clinical outcomes through personalized, omnichannel experiences. Reported outcomes include 2x–17x improvement in call-to-action rates and significant increases in user engagement and conversion for pharma/biotech brands.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

CooperSurgicalMultiple top 20 global pharma companiesVarious mid-size and emerging biotechs

Beyond the preview

Go deeper on Ostro.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ostro.

Explore the full profile